Cure8 trial brief
The study targets disparities in medication benefit and quality of life among Hispanic and Non-Hispanic Black IBD patients and seeks psychosocial factors that could be changed to improve equity.
Adult IBD patients (especially Hispanic and Non-Hispanic Black patients), caregivers, gastroenterology clinicians, health services researchers, and teams working on access or adherence interventions.
This is a cross-sectional survey study (planned enrollment ~366–400) conducted at Montefiore and Mount Sinai.
Adult patients with Crohn’s disease, ulcerative colitis, or indeterminate colitis completed a single ~20-minute validated questionnaire assessing social domains, self-reported IBD medication adherence (adapted Hill Bone Medication Adherence Scale) and HRQoL (PROMIS-29).
The protocol focuses on comparing Hispanic and Non-Hispanic Black participants with Non-Hispanic White participants and excludes other race/ethnicity groups. The study is observational and uses self-reported measures collected at one time point, so it can identify associations but cannot prove causation.
Results would be most useful for targeting later interventions to improve equity in access, adherence, and HRQoL.
This is a completed cross-sectional, self-report survey study—useful for identifying associations and targets for interventions but not for establishing cause-and-effect. The registry record describes planned methods and outcomes rather than published results.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The trial could show whether a smart-label app plus clinician alerts improves medication adherence and downstream clinical outcomes for people with Crohn's disease or ulcerative colitis starting oral or subcutaneous...
The trial explores whether morning bright light therapy can improve gut barrier function, inflammation, the microbiome, and quality of life in people with IBD who have disrupted sleep/circadian patterns—potentially...
The study tests whether combining a standardized coping-skills program with biologic therapy improves emotional well-being and clinical/endoscopic outcomes in people with early Crohn's disease—addressing common...
